33195000, 33195100, 33195110, 33157000 These are devices that monitor SpO2 (blood oxygen saturation) and /or CO2 (carbon dioxide) and their associated products. These devices include finger, wrist, hand-held and bedside monitors, along with their consumable products which include cables, wraps, single use and reusable sensors. This Framework Agreement is for 2 years with the option to extend for 24 months Additional information: OJEU Ref 2015/S 081-143112
- Procurement
- Pulse Oximetry
- Buyer
- NHS SUPPLY CHAIN
- Published
- 18 Nov 2016
- Status
- complete
- CPV
- 33195000 — Patient-monitoring system
- Tender period
- — – 22 May 2015
Awards
- Albert Waeschle Limitedactive—
- Covidien (UK) Commercial Limitedactive—
- Daray Limitedactive—
- Flexicare Medical Limitedactive—
- GE Medical Systems Limitedactive—
- Henleys Medical Supplies Limitedactive—
- Huntleigh Healthcare Limitedactive—
- Masimo Europe Limitedactive—
- Matz Medical Limitedactive—
- Med Matters Ltdactive—
- Medacx Limitedactive—
- Meditech Systems Ltdactive—
- Mindray (UK) Limitedactive—
- Penlon Limitedactive—
- Philips Electronics UK Limitedactive—
- Physio-Control UK Sales Ltdactive—
- PROACT Medical Limitedactive—
- ResMed (UK) Limitedactive—
- SISK Healthcare (UK) Ltd T/A Cardiac Servicesactive—
- S.L.E Limitedactive—
- Smiths Medical International Limitedactive—
- Tenacore UK Limitedactive—
- Timesco Healthcare Limitedactive—
- White Medicalactive—
- Williams Medical Supplies Limitedactive—
Other notices in this procurement
This is the only notice on record.
FAQs about this notice
What type of notice is this?
This is a award notice published via Contracts Finder on 18 Nov 2016.
Which procurement does this notice belong to?
It is part of "Pulse Oximetry", published by NHS SUPPLY CHAIN.
Has this notice resulted in an award?
25 awards are recorded on this notice, including to Albert Waeschle Limited.
Get the full procurement picture
Enable turns the UK's public-contract data into pipeline intelligence for bid and capture teams. Talk to us about access, alerts and tailored market analysis.
Get in touch with Enable